MINERALYS THERAPEUTICS INC (MLYS) Institutional Shareholders
MINERALYS THERAPEUTICS INC (MLYS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.42B in MLYS holdings during the latest filing period.
Catalys Pacific, Llc is currently the largest disclosed institutional shareholder of MLYS tracked by InsiderSet, reporting ownership valued at approximately $214.11M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $201.71M, representing an estimated loss of -5.80% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 50% of the total disclosed MLYS value among the investors covered in this analysis. Major shareholders include Catalys Pacific, Llc, Ra Capital Management, L.P., Samsara Biocapital, Llc, and several other long-term asset managers with concentrated positions in MINERALYS THERAPEUTICS INC (MLYS).
This page ranks the largest institutional MLYS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
210
Total Reported Value
$2.42B
Largest Holder
Catalys Pacific, Llc
Largest Position
$214.11M
Insider Transactions (90d)
20
Latest Filing Quarter
Q2 2026
New Institutional Positions
134
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Catalys Pacific, Llc | 92.81% | 7,903,838 | $214,114,971 | $201,705,946 | -$12,409,025 | -5.80% | |
| Ra Capital Management, L.P. | 2.21% | 7,692,750 | $208,396,598 | $196,318,980 | -$12,077,618 | -5.80% | |
| Samsara Biocapital, Llc | 15.45% | 5,871,018 | $159,045,878 | $149,828,379 | -$9,217,499 | -5.80% | |
| Fmr Llc | 0.01% | 4,861,104 | $131,687,318 | $124,055,374 | -$7,631,944 | -5.80% | |
| Blackrock, Inc. | 0.00% | 4,481,582 | $121,406,057 | $114,369,973 | -$7,036,084 | -5.80% | |
| Wellington Management Group Llp | 0.02% | 3,359,068 | $90,997,151 | $85,723,415 | -$5,273,736 | -5.80% | |
| State Street Corp | 0.00% | 2,935,940 | $79,534,615 | $74,925,189 | -$4,609,426 | -5.80% | |
| Caligan Partners Lp | 5.31% | 2,772,654 | $75,111,197 | $70,758,130 | -$4,353,067 | -5.80% | |
| Vanguard Capital Management Llc | 0.00% | 2,454,363 | $66,488,694 | $62,635,344 | -$3,853,350 | -5.80% | |
| Laurion Capital Management Lp | 5.67% | 2,232,040 | $60,465,964 | $56,961,661 | -$3,504,303 | -5.80% | |
| Orbimed Advisors Llc | 1.21% | 2,052,900 | $55,613,061 | $52,390,008 | -$3,223,053 | -5.80% | |
| Point72 Asset Management, L.P. | 0.09% | 1,911,433 | $51,780,720 | $48,779,770 | -$3,000,950 | -5.80% | |
| Franklin Resources Inc | 0.01% | 1,784,662 | $48,346,494 | $45,544,574 | -$2,801,920 | -5.80% | |
| Andera Partners | 20.80% | 1,591,917 | $42,949,921 | $40,625,722 | -$2,324,199 | -5.41% | |
| Sr One Capital Management, Lp | 4.63% | 1,563,966 | $42,367,839 | $39,912,412 | -$2,455,427 | -5.80% | |
| Suvretta Capital Management, Llc | 1.13% | 1,538,662 | $41,682,354 | $39,266,654 | -$2,415,700 | -5.80% | |
| Polar Capital Holdings Plc | 0.18% | 1,500,749 | $40,655,290 | $38,299,114 | -$2,356,176 | -5.80% | |
| Pictet Asset Management Holding Sa | 0.04% | 1,430,649 | $38,598,910 | $36,510,162 | -$2,088,748 | -5.41% | |
| Sphera Funds Management Ltd. | 6.24% | 1,339,971 | $36,299,814 | $34,196,060 | -$2,103,754 | -5.80% | |
| Alliancebernstein L.P. | 0.01% | 975,961 | $35,417,625 | $24,906,525 | -$10,511,100 | -29.68% | |
| Geode Capital Management, Llc | 0.00% | 1,301,135 | $35,254,696 | $33,204,965 | -$2,049,731 | -5.81% | |
| Jennison Associates Llc | 0.02% | 1,266,174 | $34,300,654 | $32,312,760 | -$1,987,894 | -5.80% | |
| Armistice Capital, Llc | 1.05% | 1,176,000 | $31,857,840 | $30,011,520 | -$1,846,320 | -5.80% | |
| Bank Of America Corp | 0.00% | 1,100,372 | $29,809,078 | $28,081,493 | -$1,727,585 | -5.80% | |
| Boothbay Fund Management, Llc | 0.63% | 1,001,728 | $27,136,812 | $25,564,099 | -$1,572,713 | -5.80% | |
| Qube Research & Technologies Ltd | 0.04% | 914,728 | $24,779,982 | $23,343,859 | -$1,436,123 | -5.80% | |
| Nantahala Capital Management, Llc | 1.51% | 895,481 | $24,258,580 | $22,852,675 | -$1,405,905 | -5.80% | |
| D. E. Shaw & Co., Inc. | 0.02% | 887,192 | $24,034,031 | $22,641,140 | -$1,392,891 | -5.80% | |
| American Century Companies Inc | 0.01% | 884,107 | $23,950,523 | $22,562,411 | -$1,388,112 | -5.80% | |
| Morgan Stanley | 0.00% | 849,184 | $23,004,437 | $21,671,176 | -$1,333,261 | -5.80% | |
| Candriam S.C.A. | 0.11% | 801,904 | $21,723,579 | $20,464,590 | -$1,258,989 | -5.80% | |
| Goldman Sachs Group Inc | 0.00% | 785,043 | $21,266,815 | $20,034,297 | -$1,232,518 | -5.80% | |
| Affinity Asset Advisors, Llc | 1.19% | 750,000 | $20,317,500 | $19,140,000 | -$1,177,500 | -5.80% | |
| Integral Health Asset Management, Llc | 1.08% | 750,000 | $20,317,500 | $19,140,000 | -$1,177,500 | -5.80% | |
| Vanguard Portfolio Management Llc | 0.00% | 706,658 | $19,143,365 | $18,033,912 | -$1,109,453 | -5.80% | |
| Aberdeen Group Plc | 0.03% | 689,235 | $18,595,560 | $17,589,277 | -$1,006,283 | -5.41% | |
| Troluce Capital Advisors Llc | 1.88% | 655,000 | $17,743,950 | $16,715,600 | -$1,028,350 | -5.80% | |
| Citadel Advisors Llc | 0.01% | 600,041 | $16,255,111 | $15,313,046 | -$942,065 | -5.80% | |
| Stempoint Capital Lp | 2.82% | 533,378 | $14,449,210 | $13,611,807 | -$837,403 | -5.80% | |
| Millennium Management Llc | 0.01% | 525,260 | $14,229,293 | $13,404,635 | -$824,658 | -5.80% | |
| Davern Capital Partners, Lp | 3.32% | 447,153 | $12,113,375 | $11,411,345 | -$702,030 | -5.80% | |
| 22Nw, Lp | 8.25% | 444,325 | $12,036,764 | $11,339,174 | -$697,590 | -5.80% | |
| Charles Schwab Investment Management Inc | 0.00% | 443,898 | $12,025,197 | $11,328,277 | -$696,920 | -5.80% | |
| Northern Trust Corp | 0.00% | 442,874 | $11,997,457 | $11,302,144 | -$695,313 | -5.80% | |
| Rock Springs Capital Management Lp | 0.70% | 439,751 | $11,912,855 | $11,222,446 | -$690,409 | -5.80% | |
| Catalio Capital Management, Lp | 2.48% | 439,041 | $11,893,621 | $11,204,326 | -$689,295 | -5.80% | |
| Capital World Investors | 0.00% | 398,179 | $10,786,669 | $10,161,528 | -$625,141 | -5.80% | |
| Renaissance Technologies LLC | Jim Simons | 0.02% | 382,800 | $10,370,052 | $9,769,056 | -$600,996 | -5.80% |
| Parkman Healthcare Partners Llc | 1.07% | 380,137 | $10,297,911 | $9,701,096 | -$596,815 | -5.80% | |
| Vanguard Fiduciary Trust Co | 0.00% | 375,262 | $10,165,848 | $9,576,686 | -$589,162 | -5.80% |
Frequently asked questions about MLYS
Who owns the most MLYS stock?
The largest holders of MLYS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for MINERALYS THERAPEUTICS INC (MLYS).
Is MLYS widely held by superinvestors?
Many widely followed stocks like MLYS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly MLYS is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.